Pushing boundaries beyond current standards, future of pulmonology – research, innovation & unmet needs explores next-generation concepts that could redefine the field. From lung organoids and AI-derived drug discovery platforms to CRISPR-based correction of genetic lung disorders, early-phase breakthroughs are rapidly moving toward clinical application. Research is increasingly focused on identifying mechanistic pathways in rare and idiopathic respiratory diseases, such as pulmonary alveolar proteinosis and lymphangioleiomyomatosis. Future of Pulmonology – Research, Innovation & Unmet Needs brings attention to underfunded areas, including sex-specific disease expression, climate-lung interactions, and access to cutting-edge care in low-resource settings. Interdisciplinary research teams are leveraging nanomedicine, 4D imaging, and bioprinting technologies to overcome current limitations in diagnosis and treatment. The roadmap ahead demands sustained funding, ethical oversight, and inclusive innovation to ensure the field progresses equitably and impactfully.
Title : Screening questionnaires for obstructive sleep apnea: An updated systematic review
Behzad Rahmati, Isfahan University of Medical Sciences, Iran (Islamic Republic of)
Title : Improving covid 19 candidate vaccine response through probiotics and micronutrient supplementation: Evaluating the role of TLR5
Zohre Eftekhari, Biotechnology Research Center, Pasteur Institute of Iran, Iran (Islamic Republic of)
Title : Novel signaling mechanisms and innovative therapeutic strategies of pulmonary hypertension
Yong Xiao Wang, Albany Medical College, United States
Title : Iatrogenic pneumothorax following nephrectomy: Case report
Chaimae Tahiri, National University Hospital Center of Fann, Senegal
Title : Towards the experience and view of personalized and precision pulmonology: An option for clinicians, geneticists and caregivers to realize the potential of genomics informed lung cancer care to secure the individualized human biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Opioid induced hypoventilation and sleep related hypoxemia in a patient on buprenorphine naloxone an underrecognized problem.
Anusha Devarajan, University of Vermont Medical Center, United States